Filtered By:
Infectious Disease: Hepatitis C

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 40423 results found since Jan 2013.

Complementary and Alternative Medicines for the Treatment of Hepatitis C: Perspectives of Users and CAM Practitioners.
Conclusions: Patients' beliefs in CAM, side effects of allopathic therapy, high cost of allopathic medicines, and referrals from previous CAM users are key factors in the switching of hepatitis C patients to CAM. PMID: 33381199 [PubMed]
Source: Evidence-based Complementary and Alternative Medicine - January 2, 2021 Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research

Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH)
Conclusion: Anger issues need close monitoring in HIV–HCV-co-infected patients, especially in patients with addictive behaviors. Screening for problems in anger management and implementing individualized psychotherapeutic strategies may help improve QoL in this population.
Source: European Journal of Gastroenterology and Hepatology - June 2, 2017 Category: Gastroenterology Tags: Original Articles: Hepatitis Source Type: research

Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
RARITAN, N.J., November 3, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson are committed to redefining treatment outcomes in the hematology setting and today announced that abstracts from more than 50 company-sponsored studies, plus more than 20 investigator-initiated studies, will be presented at the American Society of Hematology (ASH) Annual Meeting in New Orleans from December 10-13, 2022. Janssen’s commitment to advancing an innovative portfolio of therapies for healthcare professionals and patients is evidenced through more than 70 presentations that span clinical studies and r...
Source: Johnson and Johnson - November 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Prevalence and Risk Factors Associated with Hepatitis B and C in Nawabshah, Sindh, Pakistan.
Abstract In Pakistan, viral hepatitis is a serious public health problem affecting millions of people. Both hepatitis B and hepatitis C infections are spreading rapidly in all provinces of Pakistan, including Sindh, because of lack of knowledge about routes of transmission, low literacy rate, reuse of syringes, piercing, and other factors. However, information about the prevalence and risk factors is inadequate. So, a general population-based study was conducted to determine the prevalence rate and risk factors of hepatitis B and hepatitis C in Nawabshah. Healthy individuals were screened for hepatitis B and hepat...
Source: The American Journal of Tropical Medicine and Hygiene - December 21, 2020 Category: Tropical Medicine Authors: Samo AA, Laghari ZA, Baig NM, Khoso GM Tags: Am J Trop Med Hyg Source Type: research

Perceptions of Barriers and Benefits of HCV Treatment and Correlates to Treatment Intention in Methadone Patients.
The objective of this study was to assess this population's perceptions of HCV treatment. We surveyed 100 HCV+ MMT patients from four urban programs, asking scaled attitude scores about factors that may affect treatment decisions. Using bivariate and ordinal regression methods, results indicated that while education level and previous discussion about treatment with providers were associated with treatment initiation interest, age, race, gender, insurance type, difficulty paying for health care, and time since screening were not. Those who (a) believed HCV treatment is easy to take and cures quickly, (b) have had positive ...
Source: Journal of Health Care for the Poor and Underserved - November 5, 2019 Category: International Medicine & Public Health Authors: Jessop AB, Bass SB, Gutierrez M, Gashat MT Tags: J Health Care Poor Underserved Source Type: research

Early Virologic Responses and Hematologic Safety of Direct-Acting Antiviral Therapies in Veterans With Chronic Hepatitis C
Conclusions: HCV-infected veterans treated in routine medical practice with DAA-based regimens (BOC or TVR) had rates of early response comparable with those reported in clinical trials. However, they had higher rates of futility and early discontinuation than clinical trial participants. Further studies are needed to determine rates of sustained viral response.
Source: Clinical Gastroenterology and Hepatology - March 25, 2013 Category: Gastroenterology Authors: Pamela S. Belperio, Elizabeth W. Hwang, I. Chun Thomas, Larry A. Mole, Ramsey C. Cheung, Lisa I. Backus Tags: Pancreas, Biliary Tract, and Liver Source Type: research

Perceived Medical Risks of Drinking, Alcohol Consumption, and Hepatitis C Status Among Heavily Drinking HIV Primary Care Patients
ConclusionsOver one‐third of HIV patients are unaware of the medical risks of drinking, and do not restrict use, suggesting the need for intervention in this group. Patients coinfected with HIV/HCV may report more effort to restrict drinking, but their reported drinking quantity and frequency suggest that they are actually drinking just as heavily as HIV mono‐infected patients. Awareness of medical risk was unrelated to drinking, which suggests the need for interventions consisting of more than simple education. However, reported effort to restrict drinking did predict less drinking, suggesting the importance of patien...
Source: Alcoholism: Clinical and Experimental Research - January 7, 2015 Category: Addiction Authors: Jennifer C. Elliott, Efrat Aharonovich, Ann O'Leary, Barbara Johnston, Deborah S. Hasin Tags: Epidemiology, Diagnosis and Comorbidity Source Type: research

Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Conclusions HCV infection is associated with an increased risk of developing chronic kidney disease in the adult general population.
Source: Digestive Diseases and Sciences - November 20, 2015 Category: Gastroenterology Source Type: research

Effectiveness and safety of daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: systematic review and meta ‐analysis
Conclusionsdaclatasvir plus asunaprevir provides a highly effective and well tolerated treatment option for patients with HCV genotype 1b. . However, patients with NS5A RAVs at baseline should be assessed to optimize more potent DAA therapies.
Source: Journal of Gastroenterology and Hepatology - September 5, 2016 Category: Gastroenterology Authors: Hui ‐Lian Wang, Xi Lu, Xudong Yang, Nan Xu Tags: Meta Analysis and Systematic Review Source Type: research

The elderly and direct antiviral agents: constraint or challenge?
direct antiviral agents (DAAs) for chronic hepatitis C showed great effectiveness and good safety profile. So far, few data are available about their use in elderly subjects.
Source: Digestive and Liver Disease - June 1, 2017 Category: Gastroenterology Authors: Claudia Fabrizio, Annalisa Saracino, Luigia Scudeller, Eugenio Milano, Raffaele Dell ’Acqua, Giuseppe Bruno, Sergio Lo Caputo, Laura Monno, Michele Milella, Gioacchino Angarano Tags: Liver, Pancreas and Biliary Tract Source Type: research

Donor and Recipient Matching in Facial Vascularized Composite Allotransplantation: A Closer Look at the Donor Pool
Conclusions: Actual facial vascularized composite allotransplant wait times vary considerably. Although most patients experience acceptable wait times, some with underrepresented characteristics exceed acceptable levels. Cytomegalovirus-seropositive donors present a large portion of the donor pool, and exclusion for seronegative patients may increase wait time. Hepatitis C–seropositive donors may constitute a donor pool for underrepresented patient groups in the future.
Source: Plastic and Reconstructive Surgery - July 1, 2021 Category: Cosmetic Surgery Tags: Reconstructive: Head and Neck: Special Topic Source Type: research

Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C
Background & Aims: The slow asymptomatic progression of chronic hepatitis C (CHC) can be interrupted by an acute exacerbation, characterized by increased serum levels of alanine aminotransferase (ALT) and bilirubin and other symptoms of acute hepatitis. We aimed to provide more information about the clinical presentation of acute exacerbation of CHC. Methods: We identified 82 consecutive patients, from 2 locations in Italy, who had an acute exacerbation of CHC from January 2005 through June 2010; we followed them up for a median period of 36 months. These cases were hepatitis C virus (HCV) RNA positive, hepatitis B surf...
Source: Clinical Gastroenterology and Hepatology - April 15, 2013 Category: Gastroenterology Authors: Evangelista Sagnelli, Mariantonietta Pisaturo, Maria Stanzione, Vincenzo Messina, Loredana Alessio, Caterina Sagnelli, Mario Starace, Giuseppe Pasquale, Nicola Coppola Tags: Pancreas, Biliary Tract, and Liver Source Type: research

Efficacy and Safety of Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease
Conclusions: In conjunction with data from the literature, our findings indicate that the efficacy and safety of HCV therapy with IFN and ribavirin for patients with IBD are comparable to those of subjects without IBD.
Source: Clinical Gastroenterology and Hepatology - July 25, 2013 Category: Gastroenterology Authors: Alina M. Allen, W. Ray Kim, Joseph Larson, Edward V. Loftus Tags: Pancreas, Biliary Tract, and Liver Source Type: research

Updated HHS Adult and Adolescent Antiretroviral Treatment Guidelines Released
The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents announces the release of the updated Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Key updates to the guidelines include additions and changes to the following guideline sections: What to Start: Significant changes to the list of Recommended, Alternative, and Other regimens for treatment-naive patients prompted by recent findings from clinical trials and cohort studies, as well as experience in clinical practice. Addition of a new table to assist clinicians in selecting an initial ARV regimen based on...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - April 8, 2015 Category: Infectious Diseases Source Type: news